Lab-on-chip-based platform for fast molecular diagnosis of multidrug-resistant tuberculosis

Journal of Clinical Microbiology

Volumn 53, Issue 12, 2015, Pages 3876-3880

  Cabibbe, Andrea M ^a   Miotto, Paolo ^a   Moure, Raquel ^b   Alcaide, Fernando ^b   Feuerriegel, Silke ^c   Pozzi, Gianni ^d   Nikolayevskyy, Vladislav ^e,f   Drobniewski, Francis ^e,f   Niemann, Stefan ^c   Reither, Klaus ^g,h   Cirillo, Daniela M ^a   Di Pietro, Patrizia ⁱ   San Biagio, Floriana ⁱ   Alessi, Enrico ⁱ   Barbuzzi, Tony G ⁱ   Tafaj, Silva ^j   Bachiyska, Elizabetha ^k   Kontsevaya, Irina ^l   Balabanova, Yanina ^e,f   Lazzeri, Elisa ^d   Sserunkuma, Joseph ^m   Aloi, Francesco ^m   Nsubuga, Martin ^m   Sasamalo, Mohamed ^h   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c RESEARCH CENTER BORSTEL   (Germany)

^d UNIVERSITY OF SIENA   (Italy)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^h IFAKARA HEALTH INSTITUTE   (Tanzania)

ⁱ STMICROELECTRONICS   (Italy)

^j UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^k NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^l Samara TB Service   (Russian Federation)

^m Nsambya Home Care   (Uganda)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; INHA GENE; KATG GENE; LAB ON A CHIP; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; DRUG EFFECTS; EVALUATION STUDY; HUMAN; MULTIDRUG RESISTANCE; PROCEDURES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ISONIAZID; LAB-ON-A-CHIP DEVICES; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84947736301     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01824-15     Document Type: Article

References (26)

1. World Health Organization. (2014). Global tuberculosis report 2014. World Health Organization, Geneva, Switzerland
2. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. (2014). Tuberculosis surveillance and monitoring in Europe 2014. European Centre for Disease Prevention and Control, Stockholm, Sweden
3. Drobniewski F, Nikolayevskyy V, Balabanova Y, Bang D, Papaventsis D. (2012). Diagnosis of tuberculosis and drug resistance: what can new tools bring us? Int J Tuberc Lung Dis 16: 860-870. http://dx.doi.org/10.5588/ijtld.12.0180
4. Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A. (2013). Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 13: 349-361. http://dx.doi.org/10.1016/S1473-3099(13)70008-2
5. Luetkemeyer AF, Kendall MA, Wu X, Lourenço MC, Jentsch U, Swindells S, Qasba SS, Sanchez J, Havlir DV, Grinsztejn B, Sanne IM, Firnhaber C, Adult AIDS Clinical Trials Group A5255 Study Team. (2014). Evaluation of two line probe assays for rapid detection of mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB mycobacteria in HIV-infected individuals with suspected TB. J Clin Microbiol 52: 1052-1059. http://dx.doi.org/10.1128/JCM.02639-13
6. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. (2014). Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1: CD009593. http://dx.doi.org/10.1002/14651858.CD009593.pub3
7. Bwanga F, Hoffner S, Haile M, Joloba ML. (2009). Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 9: 67. http://dx.doi.org/10.1186/1471-2334-9-67
8. Sanchez-Padilla E, Merker M, Beckert P, Jochims F, Dlamini T, Kahn P, Bonnet M, Niemann S. (2015). Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med 372: 1181-1182. http://dx.doi.org/10.1056/NEJMc1413930
9. Köser CU, Feuerriegel S, Summers DK, Archer JA, Niemann S. (2012). Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance. Antimicrob Agents Chemother 56: 6080-6087. http://dx.doi.org/10.1128/AAC.01641-12
10. Mathys V, van De Vyvere M, De Droogh E, Soetaert K, Groenen G. (2014). False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene. Int J Tuberc Lung Dis 18: 1255-1257. http://dx.doi.org/10.5588/ijtld.14.0297
11. Ocheretina O, Escuyer VE, Mabou MM, Royal-Mardi G, Collins S, Vilbrun SC, Pape JW, Fitzgerald DW. (2014). Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results. PLoS One 9: e90569. http://dx.doi.org/10.1371/journal.pone.0090569
12. World Health Organization. (2014). High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting. World Health Organization, Geneva, Switzerland
13. Miotto P, Cabibbe AM, Mantegani P, Borroni E, Fattorini L, Tortoli E, Migliori GB, Cirillo DM. (2012). GenoType MTBDRsl performance on clinical samples with diverse genetic background. Eur Respir J 40: 690-698. http://dx.doi.org/10.1183/09031936.00164111
14. World Health Organization. (1998). Laboratory services in tuberculosis control. Part II. Microscopy. WHO/TB/98.258. World Health Organization, Geneva, Switzerland
15. Miotto P, Saleri N, Dembelé M, Ouedraogo M, Badoum G, Pinsi G, Migliori GB, Matteelli A, Cirillo DM. (2009). Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso. BMC Infect Dis 9: 142. http://dx.doi.org/10.1186/1471-2334-9-142
16. Global Laboratory Initiative. (2014). Mycobacteriology laboratory manual, 1st ed. Global Laboratory Initiative, World Health Organization, Geneva, Switzerland
17. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. (2006). Use of Genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 44: 2485-2491. http://dx.doi.org/10.1128/JCM.00083-06
18. Pernagallo S, Ventimiglia G, Cavalluzzo C, Alessi E, Ilyine H, Bradley M, Diaz-Mochon JJ. (2012). Novel biochip platform for nucleic acid analysis. Sensors (Basel) 12: 8100-8111. http://dx.doi.org/10.3390/s120608100
19. Sackmann EK, Fulton AL, Beebe DJ. (2014). The present and future role of microfluidics in biomedical research. Nature 507: 181-189. http://dx.doi.org/10.1038/nature13118
20. Foudeh AM, Fatanat Didar T, Veres T, Tabrizian M. (2012). Microfluidic designs and techniques using lab-on-a-chip devices for pathogen detection for point-of-care diagnostics. Lab Chip 12: 3249-3266. http://dx.doi.org/10.1039/c2lc40630f
21. Lazzeri E, Santoro F, Oggioni MR, Iannelli F, Pozzi G. (2012). Novel primer-probe sets for detection and identification of mycobacteria by PCR-microarray assay. J Clin Microbiol 50: 3777-3779. http://dx.doi.org/10.1128/JCM.02300-12
22. Guo Y, Zhou Y, Wang C, Zhu L, Wang S, Li Q, Jiang G, Zhao B, Huang H, Yu H, Xing W, Mitchelson K, Cheng J, Zhao Y. (2009). Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. Int J Tuberc Lung Dis 13: 914-920
23. Moure R, Tudó G, Medina R, Vicente E, Caldito JM, Codina MG, Coll P, Español M, Gonzalez-Martin J, Rey-Jurado E, Salvadó M, Tórtola MT, Alcaide F. (2013). Detection of streptomycin and quinolone resistance in Mycobacterium tuberculosis by a low-density DNA array. Tuberculosis (Edinb) 93: 508-514. http://dx.doi.org/10.1016/j.tube.2013.07.001
24. Moure R, Español M, Tudó G, Vicente E, Coll P, Gonzalez-Martin J, Mick V, Salvadó M, Alcaide F. (2014). Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array. J Antimicrob Chemother 69: 947-954. http://dx.doi.org/10.1093/jac/dkt448
25. Tan JJ, Capozzoli M, Sato M, Watthanaworawit W, Ling CL, Mauduit M, Malleret B, Grüner AC, Tan R, Nosten FH, Snounou G, Rénia L, Ng LF. (2014). An integrated lab-on-chip for rapid identification and simultaneous differentiation of tropical pathogens. PLoS Negl Trop Dis 8: e3043. http://dx.doi.org/10.1371/journal.pntd.0003043
26. Teo J, Di Pietro P, San Biagio F, Capozzoli M, Deng YM, Barr I, Caldwell N, Ong KL, Sato M, Tan R, Lin R. (2011). VereFlu™: an integrated multiplex RT-PCR and microarray assay for rapid detection and identification of human influenza A and B viruses using lab-on-chip technology. Arch Virol 156: 1371-1378. http://dx.doi.org/10.1007/s00705-011-0999-7